Hutch News

Hutch News

Stories tagged 'Oliver Press'

Dr. Stephanie Lee honored as new Giuliani/Press Endowed Chair recipient

The honor will support Lee in perpetuity as she continues her research on blood stem cell transplantation and chronic GVHD

Oct. 17, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch physician-scientist Dr. Stephanie Lee, the second recipient of the David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, was honored at an Oct. 12 ceremony at Fred Hutch.

View story >


Dr. Beverly Torok-Storb wins mentorship award

1st Oliver Press Award for Extraordinary Mentorship named in honor of late Hutch scientist

Oct. 4, 2018 | By Susan Keown / Fred Hutch News Service

Dr. Beverly Torok-Storb — “Dr. Bev” — received the first Oliver Press Award for Extraordinary Mentorship. Torok-Storb has founded and led several internship programs, with a focus on students from underrepresented groups.

View story >


Dr. Phil Greenberg named 2018 Leader in Health Care

Seattle Business Magazine honors cancer immunotherapy pioneer for his work on T-cell therapy

March 2, 2018 | By Susan Keown / Fred Hutch News Service

Seattle Business Magazine honors Fred Hutch cancer immunotherapy pioneer Dr. Phil Greenberg with 2018 Leaders in Health Care Gold Award for Achievement in Medical Research.

View story >


How cancer survivors are teaching researchers — even decades later

Tracking survivors long after treatment ends helps inform medical decisions for today’s patients and much more

Jan. 26, 2018 | By Rachel Tompa / Fred Hutch News Service

Every year since its inception in the early 1980s, the Fred Hutch Long-term Follow-up Program sends out a detailed questionnaire to every transplant survivor. The answers to these questions inform a host of research topics on the long-term effects of transplantation, from graft-vs.-host disease to cataracts, from secondary cancers to infertility and sexual dysfunction.

View story >


Mourning the loss of Dr. Oliver 'Ollie' Press

Lymphoma physician-scientist, leader and mentor made lifesaving contributions to the development of targeted cancer therapies

Oct. 2, 2017 | by Susan Keown / Fred Hutch News Service

Dr. Oliver Press died of complications from glioma, a brain cancer. Press was a physician-scientist who made foundational contributions to the development of targeted therapies for blood cancers.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.